[PDF][PDF] Deciphering the dilemma: anticoagulation for heart failure with preserved ejection fraction (HFpEF)
FNU Jyotsna, K Mahfooz, H Sohail, S Kumar, M Adeeb… - Cureus, 2023 - cureus.com
Impairment in ventricular relaxation and preserved left ventricular ejection fraction are the
two main features of heart failure with preserved ejection fraction (HFpEF) a difficult clinical …
two main features of heart failure with preserved ejection fraction (HFpEF) a difficult clinical …
Oral anticoagulant switching in patients with atrial fibrillation: a scoping review
Introduction Oral anticoagulants (OACs) prevent stroke in patients with atrial fibrillation (AF).
Several factors may cause OAC switching. Objectives To examine the phenomenon of OAC …
Several factors may cause OAC switching. Objectives To examine the phenomenon of OAC …
Oral anticoagulant adherence and switching in patients with atrial fibrillation: a prospective observational study
Background Adherence to oral anticoagulants (OACs) in patients with atrial fibrillation (AF) is
important in preventing stroke. The dominance of retrospective studies using administrative …
important in preventing stroke. The dominance of retrospective studies using administrative …
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study
S Testa, G Palareti, C Legnani, C Dellanoce… - Blood …, 2024 - ashpublications.org
Although effective and safe, treatment with direct oral anticoagulants (DOAC) in atrial
fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of …
fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of …
Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study
Introduction Proton pump inhibitors (PPIs) are widely used for primary and secondary
prevention of upper gastrointestinal bleeding. However, there remains controversy about the …
prevention of upper gastrointestinal bleeding. However, there remains controversy about the …
Innovations in pharmacovigilance studies of medicines in older people
Pharmacovigilance is defined by the World Health Organization as “the science and
activities relating to the detection, assessment, understanding and prevention of adverse …
activities relating to the detection, assessment, understanding and prevention of adverse …
Differences in the location of bleeding with direct oral anticoagulants vs. vitamin K antagonists: A study in the World Health Organization's pharmacovigilance …
JL Montastruc, S Tessier… - British Journal of Clinical …, 2023 - Wiley Online Library
Aims Clinical trials have found differences in bleeding locations between direct oral
anticoagulants (DOAC) and vitamin K antagonists (VKA). The present study was performed …
anticoagulants (DOAC) and vitamin K antagonists (VKA). The present study was performed …
Development and Application of an Attribute-Based Taxonomy on the Benefits of Oral Anticoagulant Switching in Atrial Fibrillation: A Delphi Study
Introduction Patients with atrial fibrillation (AF) often switch between oral anticoagulants
(OACs). It can be hard to know why a patient has switched outside of a clinical setting …
(OACs). It can be hard to know why a patient has switched outside of a clinical setting …
Time to invest in team-based care
MB Trusler - Canadian Family Physician, 2023 - cfp.ca
February 2023 issue of Canadian Family Physician1 encouraging the adoption of team-
based care as one solution to alleviating the current strain on our family physician resources …
based care as one solution to alleviating the current strain on our family physician resources …
[HTML][HTML] Protocol: Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study
ABSTRACT Introduction Proton pump inhibitors (PPIs) are widely used for primary and
secondary prevention of upper gastrointestinal bleeding. However, there remains …
secondary prevention of upper gastrointestinal bleeding. However, there remains …